Anti-HHV8 antibody [LN53] (ab4103) is a rat monoclonal antibody detecting HHV8 in IHC-P, IHC-Fr. Suitable for Human herpesvirus 8.
- Over 10 publications
- Trusted since 2003
View Alternative Names
HHV 8, Human Herpes Virus 8, KSHV, Kaposi's sarcoma associated herpes virus
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HHV8 antibody [LN53] (AB4103)
Cultured cells infected with HHV8, stained with HHV8 using ABC and DAB chromogen.
Reactivity data
Product details
Anti-HHV8 antibody [LN53] (ab4103) is a rat monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Human herpesvirus 8 samples.
Trusted by the scientific community
Anti-HHV8 [LN53] (ab4103) was first used in a scientific publication in 2003 and has been cited over 10 times in peer-reviewed journals.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HHV-8 disrupts normal cellular processes by expressing proteins like LANA (latency-associated nuclear antigen) that interfere with host cellular mechanisms. It is known to be part of complex interactions within infected cells chiefly affecting the tumor suppressor pathways. These proteins lead to changes that permit the infected cells to escape immune destruction and continue proliferating unchecked. Despite interventions the virus maintains a dormant state in the host which makes complete eradication difficult.
Pathways
HHV-8 influences two major biological pathways—the p53 signaling pathway and the NF-kB signaling pathway. The virus's interference with the p53 protein which plays a critical role in controlling cell cycle arrest and apoptosis is a major aspect of its pathogenic capacity. Additionally HHV-8 can activate the NF-kB pathway which leads to inflammation and survival signaling encouraging oncogenic transformation. This viral manipulation disrupts normal cellular homeostasis and contributes to disease manifestation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
PLoS pathogens 21:e1013029 PubMed40825050
2025
Applications
Unspecified application
Species
Unspecified reactive species
mBio 16:e0129325 PubMed40503897
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 21:e1013108 PubMed40245053
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 135: PubMed39666389
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular and infection microbiology 13:1270935 PubMed37928187
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:591 PubMed37673880
2023
Applications
Unspecified application
Species
Unspecified reactive species
Tumour virus research 15:200259 PubMed36863485
2023
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 19:e1010753 PubMed36689549
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 37:110144 PubMed34965440
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 17:e1009600 PubMed34936683
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com